Most discussions of AI-generated code focus on whether AI can write code. The harder question is whether you can trust it.

In modern drug discovery, successfully navigating the progress from molecular concept to viable therapeutic often hinges on ...

Dhillon outlined that over the next 90 days and into 2026, the company will "generate a more complete picture of nimasimab's potential using insights from our PK and PD modeling and the ongoing ...

Modella AI has signed a multi-year agreement with AstraZeneca to expedite AI-driven oncology clinical development. The partnership will give AstraZeneca access to Modella AI’s multi-modal foundation ...

As cities around the world continue to expand and evolve, understanding the dynamics of the housing market becomes increasingly critical for urban planners, ...

Using patent intelligence data from the FounderNest platform, alongside funding, partnership, and deployment signals across ...

Last year marked an inflection point for data centers. Artificial intelligence-driven development made the sector a primary engine of U.S. economic growth, turned the industry into a political issue ...